Investigation of the Effectiveness of Muscle Inhibition and Space Correction Techniques of Kinesiotaping Method in Female Patients With Myofascial Pain Syndrome Related to Upper Trapezius Active Trigger Points

To investigate the effectiveness of muscle inhibition and space correction techniques of kinesiotaping (KT) method; on pain, functional status and quality of life in female patients with myofascial pain syndrome (MPS) related to upper trapezius active trigger points (TP) in comparison to control group and to determine the advantage of each technique over another.

Study Overview

• Status: Completed
• Conditions: Female Patients With Myofascial Pain Syndrome (MPS) Related to Upper Trapezius Active Trigger Points (TP)
• Intervention / Treatment: Other: Kinesiotaping with space correction technique; Other: Home exercise program; Other: Kinesiotaping with muscle inhibition technique

Detailed Description

The investigators conducted a prospective, randomized, controlled trial involving 93 female patients with MPS related to upper trapezius TPs and randomized the patients to KT treatment group with space correction technique and home exercise program (KSCT, n=20), KT treatment group with muscle inhibition technique and home exercise program (KMIT, n=24) and control group (CG, n=27) which received home exercise program only. Patients were evaluated by numerical rating scale (NRS) for their average and maximum pain intensity, Turkish version of neck disability index (NDI), and short form-36 (SF-36) scales. Statistical tests were conducted at the 0.05 significance level for all outcome measures.

• Study Type: Interventional
• Enrollment (Actual): 93
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 45 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

• being female
• being aged between 18 and 45 years old
• not being in menopausal period
• having pain in upper trapezius region
• determining a taut band in examination
• having at least one active TP in this taut band
• the pain produced by palpation of this TP is the pain that the patient complains
• painfull restriction of cervical lateral flexion
• having pain score 4 or more according to NRS
• signing informed consent.

Exclusion Criteria:

• having major surgery or trauma related to the musculoskeletal system (primarily including the spine and upper extremity)
• having any operative history including the head and neck region
• having a neuromuscular disease
• having an active rheumatic disease
• having a systemic disease (diabetes, hypothyroidism, infection, malignancy...)
• having any pathology related to musculoskeletal diseases -especially including the cervical region- (cervical discopathy, cervical spondylosis, pathologies related to shoulder joint and surrounding soft tissues, scoliosis, kyphosis, limb length discrepancy, polio sequelae, developmental hip dysplasia...)
• having serious psychological problems (having score of 30 or more from Beck Depression Inventory)
• being obese (Body Mass Index≥30 kg/m2)
• having allergy to kinesiotapes

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Kinesiotaping with space correction technique	Other: Kinesiotaping with space correction technique; Kinesiotaping with space correction technique twice per week for two weeks along with home exercise program; Other: Home exercise program; Home exercise program which consists of stretching exercises towards neck area
Experimental: Kinesiotaping with muscle inhibition technique	Other: Home exercise program; Home exercise program which consists of stretching exercises towards neck area; Other: Kinesiotaping with muscle inhibition technique; Kinesiotaping with muscle inhibition technique twice per week for two weeks along with home exercise program
Active Comparator: Home exercise program	Other: Home exercise program; Home exercise program which consists of stretching exercises towards neck area

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in pain related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to first, second and six weeks	Pain intensity mesaurement via Numerical Rating Scale, range between 0 to 10, higher scores indicating more pain intensity	Initial assessment, First week, second week, sixth week
Change in disability related to myofascial pain syndrome due to upper trapezius active trigger points from baseline to second and six weeks	Functional status measurement via Neck Disability Index	Initial assessment, second week, sixth week
Change in quality of life affected by myofascial pain syndrome due to upper trapezius active trigger points from baseline to second and six weeks	Quality of life measurement via Short Form-36	Initial assessment, second week, sixth week

Collaborators and Investigators

• Sponsor: Dilşad Sindel

Study record dates

Study Major Dates

• Study Start (Actual): December 1, 2013
• Primary Completion (Actual): December 1, 2014
• Study Completion (Actual): December 1, 2014

Study Registration Dates

• First Submitted: May 10, 2019
• First Submitted That Met QC Criteria: May 10, 2019
• First Posted (Actual): May 14, 2019

Study Record Updates

• Last Update Posted (Actual): May 16, 2019
• Last Update Submitted That Met QC Criteria: May 14, 2019
• Last Verified: May 1, 2019

More Information

Terms related to this study

• Keywords: Myofascial pain syndrome, kinesiotaping, upper trapezius, home exercise program
• Additional Relevant MeSH Terms: Pathologic Processes; Nervous System Diseases; Disease; Musculoskeletal Diseases; Rheumatic Diseases; Muscular Diseases; Neuromuscular Diseases; Syndrome; Fibromyalgia; Myofascial Pain Syndromes
• Other Study ID Numbers: KSCT&KMIT

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No